Ridley Corporation Ltd (RIC)
Australian Securities Exchange · Australia · prices in AUD · close of 23 Oct 2026
Key indicators
| Last close | AUD 2.620 |
|---|---|
| 52-week range | 2.340 – 3.070 |
| Return, 1 month / 3 months | +3.4% / −2.6% |
| Return, 1 year / 3 years | −9.7% / +31.9% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 28.8% |
| Worst drawdown (1 year) | -20.9% |
| Average daily value traded | 2.14M AUD |
| Dividend yield | 4.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Ridley Corporation is an Australian company that makes animal nutrition products, producing feed for livestock, poultry, pigs, dairy cattle and farmed fish, and it also supplies salt for food, agricultural and industrial uses. Its customers are farmers, feedlots, aquaculture operators and food producers, mainly in Australia, and it runs manufacturing sites and sales operations serving those markets from its base in Australia.
On this site Ridley Corporation Ltd appears as a stock on the Australian Securities Exchange (Australia), code RIC, with prices in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Ridley Corporation Ltd (RIC) trades on the Australian Securities Exchange in Australia. It last closed at AUD 2.620 on 23 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 278 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 9.7% and over the last three months it fell 2.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 0.2% | ||
| From 52-week high | -13.8% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -2.6% | ||
| 6-month return | -3.3% | ||
| 12-month return, skipping the last month | -12.6% | ||
| Stability (higher is calmer) | 90 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.9% | ||
| Liquidity | 83 · Strong | Trades actively. | |
| Average daily value traded | 2.14M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 46 · Weak | Dividend is small or irregular. | |
| Dividend yield | 4.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.4% |
|---|---|
| 1 month | +3.4% |
| 3 months | −2.6% |
| 6 months | −3.3% |
| 1 year | −9.7% |
| 3 years | +31.9% |
| 5 years | +134.2% |
Signals
| 50-day / 200-day average | 2.583 / 2.615 |
|---|---|
| Golden / death cross (60 days) | Death, 6 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.064 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Oct 2026 | AUD 0.0535 |
| 1 Apr 2026 | AUD 0.0510 |
| 6 Oct 2025 | AUD 0.0500 |
| 3 Apr 2025 | AUD 0.0470 |
| 7 Oct 2024 | AUD 0.0460 |
| 3 Apr 2024 | AUD 0.0435 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.